Skip to main content
. 2018 Aug 24;32(12):1173–1181. doi: 10.1007/s40263-018-0553-1

Fig. 1.

Fig. 1

Mean a GCS and b cognitive domain scores at baseline and after 1 and 2 years of natalizumab treatment (N = 52). SD standard deviation, GCS global cognitive score